Stada to Support Takeover Bid by Bain Capital and Cinven
ByLONDON — Stada Arzneimittel of Germany said on Monday that it would support a takeover bid by the private equity firms Bain Capital and Cinven that valued it at more than $4.3 billion, in the latest potential big deal for a maker of generic drugs.
It was one of two takeover offers the company received through a structured bidding process, with Stada’s board concluding the Bain and Cinven offer was “in the best interest of the company and in the interest of the shareholders and other stakeholders.”
The offer represents a nearly 49 percent premium to the company’s closing price on Dec. 9, before rumors surfaced that a takeover might be in the works…